公开(公告)号：US20230215535A1

公开(公告)日：2023-07-06

申请号：US17996457

申请日：2021-04-20

Applicant: UNIVERSITÄT ULM

Inventor： Marc-Eric HALATSCH

IPC: G16H20/10 ,  G16H50/20

CPC classification number: G16H20/10 ,  G16H50/20

Abstract: The invention relates to a method for providing a medication combination, wherein at least one medication of the medication combination to be provided is selected on the basis of the result of a molecular in vitro characterization of tumor tissue of a glioblastoma of a patient. The selection is made on the basis of eliminating and not selecting medications from a list of non-oncological medications for which no benefit has been acknowledged for treating the patient on the basis of the result of the molecular in vitro characterization. The medication combination which can be provided using the method is inexpensive, exhibits a low degree of toxicity, and is characterized by an improved efficacy in comparison to known medication combinations. The invention additionally relates to a data carrier with software which can support or simplify the process of carrying out the method according to the invention.